文献速递前列腺增生与排尿功能障碍泌尿系感染

骶神经调控:成功预测因素的回顾性分析

Sacral Neuromodulation: Determining Predictors of Success.
PubMed 文献 · Urology · 2020-06-30

该回顾性研究纳入198例接受分期骶神经调控植入的女性,分析过度活动膀胱、尿潴留及大便失禁患者的成功预测因素。结果显示,年龄>65岁和既往A型肉毒毒素治疗是II期植入完成的负性预测因素,既往盆底物理治疗与患者报告成功负相关,而术中<4个电极运动反应不影响成功率。

要点

  • 年龄>65岁及既往A型肉毒毒素治疗与II期植入完成率降低相关。
  • 既往盆底物理治疗是患者报告术后成功的负性预测因素。
  • 术中<4个电极运动反应不影响患者报告的成功率。

核心结论

  • 年龄>65岁和既往A型肉毒毒素治疗与II期植入未完成相关。
  • 既往盆底物理治疗女性报告骶神经调控后成功的可能性更低。
  • 术中<4个电极运动反应不影响患者报告的成功。

研究设计与样本

  • 回顾性图表审查,纳入2007至2018年间接受分期骶神经调控植入的女性。
  • 共198例女性,平均年龄62.9岁(标准差±14.7)。
  • 根据术中4个电极或<4个电极出现运动反应进行分组。

主要发现

  • 92.4%的女性完成II期植入。
  • 完成II期植入的女性中,83.3%在首次术后随访报告成功。
  • 6个月时持续成功率为70.3%。
  • 电极修整率为23.0%。

关键数值与推荐

  • 年龄>65岁(OR=0.2,95%CI=0.06-0.8)和既往A型肉毒毒素治疗(OR=0.2,95%CI=0.06-0.9)是II期植入完成的负性预测因素。
  • 既往盆底物理治疗是患者报告术后成功的负性预测因素(OR=0.25,95%CI=0.1-0.6)。

临床怎么用

  • 对于年龄>65岁或既往接受A型肉毒毒素治疗的女性,应告知II期植入完成率可能较低。
  • 既往盆底物理治疗史可能降低患者报告的成功率,术前咨询需考虑此因素。
  • 术中电极运动反应少于4个不应作为排除骶神经调控的依据。

局限性

  • 回顾性研究设计。
  • 单中心图表审查。
  • 样本为女性,结论不能外推至男性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine predictors of success for sacral neuromodulation in women with overactive bladder, urinary retention, and fecal incontinence. METHODS: A retrospective chart review was performed on women who underwent a staged sacral neuromodulation implantation between 2007 and 2018. Clinical and procedural characteristics were recorded. Presence of intraoperative motor responses in either all 4 or <4 electrodes were used to group women. Endpoints included completion of stage II implant, tined lead revision, and patient-reported success. RESULTS: In 198 women with a mean age of 62.9 years (SD+/- 14.7), completion of stage II implant occurred in 92.4% of women, and 83.3% of these women reported success at the first postoperative visit. Continued success at 6 months was reported in 70.3%. Lead revision was noted in 23.0%. Age >65 years (odds ratio [OR] = 0.2, 95% confidence interval [CI] = 0.06-0.8) and prior onabotulinumtoxinA (onaBoNT-A) (OR = 0.2, 95% CI = 0.06-0.9) were negative predictors for completion of stage II implant on multivariable analysis. Also, prior pelvic floor physical therapy was a significant negative predictor of postoperative patient-reported success on multivariable analysis (OR = 0.25, 95% CI = 0.1-0.6). There were no differences seen in women who had motor responses with either all 4 electrodes or <4 electrodes in any endpoint (P > .05). CONCLUSION: Patient age >65 and history of prior onaBoNT-A were associated with failure to complete stage II implant. Women with prior pelvic floor physical therapy were less likely to report success after sacral neuromodulation. Motor responses in <4 electrodes during lead testing did not impact patient-reported success.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Morgan TN, Pace N, Mohapatra A, et al. Sacral Neuromodulation: Determining Predictors of Success. Urology. 2020. PMID: 32619594. doi:10.1016/j.urology.2020.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。